The global sinus dilation devices market is anticipated to grow at a significant CAGR of 9% during the forecast period. The major factor that is contributing to the market growth includes the rising adoption of minimally invasive procedures and a significant increase in the aging population are further encouraging market growth. For instance, According to the report published by the American Society of Plastic Surgeons in 2020, there were approximately 13.2 million minimally-invasive procedures were performed. In this 10.4 million women and 82,000 men have taken benefits of minimally-invasive surgical procedures. 

Sinus dilation devices are used to dilate obstructed sinus ostium among patients affected with sinusitis. The devices include balloon sinus dilation, endoscopic sinus surgery, sinus stents, and handheld instruments. Balloon sinus dilation devices also referred to as balloon sinuplasty is used to gently dilate blocked arteries by using tiny balloons. It enables the opening of blocked sinus passages for allowing adequate ventilation and restores natural drainage. It is a minimally invasive procedure and hence doesn't involve the removal of tissue or bone. It is performed by inserting a tiny catheter into the nose and afterward into the opening of blocked or narrowed sinuses. This procedure leads to faster recovery and minimal bleeding. Therefore, it is considered to be one of the most efficient devices for the treatment of sinusitis.

Impact of COVID-19 Pandemic On Global Sinus Dilation Devices  Market

In COVID-19 mainly surgical procedures were canceled and postponed across the globe, also the routine patient care was suspended during this time. Additionally, routine clinical visits were also canceled to stop the transmission of COVID-19 and many health organizations were focusing on the increase and maintaining the availability of intensive care and inpatient care beds which in turn delayed various health procedures. Moreover, delayed surgeries particularly for chronic rhino sinusitis affected the sinus dilation devices market attributed to less demand from healthcare organizations. However, in 4Q the demand and procedures of all the surgeries were increased and it is anticipated to drive the demand for sinus dilation devices market.

Segmental Outlook 

The global sinus dilation devices market is segmented on the basis of type and end user. On the basis of type, the market is sub-divided into sinus stents, balloon sinus dilation, endoscopic sinus surgery, and hand handheld instruments. By end-user, the market is sub-classified into hospitals and clinics, and ambulatory surgical centers. Among the end-user segment, the hospital segment is dominating owing to a major number of several procedures performed such as surgical procedures, and outpatient sinus dilation procedures. Moreover, this segment has well-established healthcare facilities, and the availability of technologically advanced infrastructures among others are such factor that is contributing to the segment's dominance in the market growth.

Global Sinus Dilation Devices Market Share By Type, 2021 (%)

The Balloon Sinus Dilation Segment is Dominating the Global Sinus Dilation Devices  Market 

Among the type segment,  balloon sinus dilation is holding a prominent share owing to the increasing demand for minimally invasive procedures, and the growing trend toward innovations in balloon sinus dilation devices is aiding in increasing the adoption of this device. Additionally, it is a new technique for performing sinus surgery and is used to treat sinusitis and other related problems also it is a minimally invasive procedure. Due to benefits associated with it such as, it is a safe technique coupled with while performing no removal of any tissue or bone is done. Regular product launches and regulatory approval are also driving the market growth. For instance, In August 2020, Acclarent Inc., a new balloon dilation system such as integrated balloon sinuplasty (BSP) and Eustachian tube (ET) dilation device, has been approved by Food and Drug Administration (FDA). The device is designed to provide a means to access the sinus space within and across nasal and sinus structures.

Regional Outlooks

The global Sinus dilation devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East &Africa, and Latin America. North America is gaining significant popularity due to the increasing prevalence of sinusitis in the region. Europe is also showing remarkable opportunity due to the high focus on offering patient-centered care coupled with the improvement in healthcare infrastructure in the region.

Global Sinus Dilation Devices  Market Growth, by Region 2022-2028

The Asia-Pacific Region Is Fastest Growing In The Global Sinus Dilation Devices  Market

The Asia-Pacific is expected to fastest growing during the forecast period due to rising awareness about sinus disease in the region. Moreover, due to increasing disposable income, developing healthcare infrastructure, and rising number of medical tourism. In addition, The key players present in the region such as Olympus Corp., and InAccel among others are contributing to the market growth by developing and launching a new products and getting approval, mergers, and acquisition to expand the business. For instance, Olympus Corp. has received FDA approval for CELERIS a sinus debrider system. This device is developed for the treatment of general ENT and sinus/rhinology procedures in some specific procedure that includes turbinoplasty, polypectomy, and endoscopic sinus surgery.

Market Players Outlook

The competitive landscape includes key strategies of leading players, recent developments, and key company analysis. The major players that contribute to the growth of the market include - Johnson & Johnson Services, Inc., Medtronic Plc., Olympus Corp, Smith & Nephew Healthcare, Stryker Corp., Teleflex Inc.,  and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2022, Medtronic Plc acquired Intersect ENT at Federal Trade Commission in this deal Fiagon will have to be sold to White Bear Lake, MN-based Hemostasis. Intersect's Fiagon subsidiary is a major competitor in the US market dealing in both systems that including ENT navigation systems and balloon sinus dilation products.

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global sinus dilation devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.